27^th Global Nephrology, Urology and Kidney Failure Congress

About us

The 27th Global Nephrology, Urology and Kidney Failure Congress, scheduled for June 15–16, 2026 in Paris, France, stands as a premier international platform dedicated to advancing renal science, urological research, and transformative kidney health solutions. Under the theme “Precision Renal Care: Integrating Regenerative Therapies, Smart Diagnostics & Advanced Kidney Health Innovations,” the congress brings together global nephrologists, urologists, researchers, technologists, surgeons, dialysis specialists, and industry leaders to explore the next era of personalized kidney medicine. This prestigious event focuses on groundbreaking developments including regenerative nephrology, stem-cell–based renal repair, bioengineered tissues, AI-driven diagnostic tools, precision surgery, wearable dialysis innovations, early detection biomarkers, and advanced pharmacotherapy for renal and urological disorders. Participants will benefit from high-level scientific sessions, keynote lectures, expert panel discussions, hands-on workshops, clinical case forums, and technology demonstrations that bridge basic research with clinical applications. The congress fosters meaningful collaborations by connecting academic scientists, hospital professionals, device manufacturers, biotech innovators, pharmaceutical specialists, and policy leaders from more than 40 countries. Designed to expand knowledge and accelerate patient-centric care, the event promotes solutions for chronic kidney disease, acute kidney injury, renal replacement therapies, minimally invasive urology, kidney transplantation, and global renal health challenges. Join us in Paris for two inspiring days of scientific excellence, networking opportunities, and strategic partnerships that drive the future of kidney care and reshape global standards in nephrology and urology.

Sessions

Renal Precision Medicine & Genomic Risk Profiling

Renal precision medicine is transforming the understanding and management of kidney diseases by integrating genomics, multi-omics, and computational modeling to identify individual risk patterns and therapeutic responses. Genomic risk profiling allows clinicians to detect hereditary predispositions, rare variants, and molecular signatures linked to glomerular, tubular, and metabolic kidney disorders long before clinical symptoms emerge. By combining whole-exome sequencing, biomarker analytics, transcriptomics, and pharmacogenomics, physicians can develop individualized treatment strategies that optimize drug efficacy and reduce nephrotoxic burden. Precision phenotyping enhances the ability to categorize patients based on molecular pathways rather than broad disease classifications, leading to targeted interventions for complex conditions such as APOL1-associated kidney disease, polycystic kidney disorders, and immune-mediated nephropathies. AI-driven algorithms and predictive models further support real-time risk stratification, enabling early identification of high-risk individuals and guiding therapeutic escalation. As precision medicine expands, it facilitates improved patient outcomes, minimized progression to end-stage renal disease, and reduced healthcare burden through proactive, personalized renal care.

Smart Nephro-Diagnostics & AI-Enabled Kidney Monitoring

Smart nephro-diagnostics represent a new era of early detection and continuous kidney health surveillance. AI-driven decision systems, digital biomarkers, and real-time monitoring tools help clinicians identify renal deterioration long before traditional tests reveal abnormalities. Wearable biosensors measure fluid balance, creatinine fluctuations, electrolyte shifts, and blood pressure trends, integrating seamlessly with cloud-based platforms for remote physician oversight. Machine learning models assess thousands of variables simultaneously, offering precise predictions for acute kidney injury, chronic kidney disease progression, and dialysis initiation timelines. Advanced point-of-care diagnostics provide rapid assessment of proteinuria, glomerular filtration rate, urinary biomarkers, and metabolic signatures linked to inflammation and fibrosis. Smart imaging techniques—including radiomics and contrast-free MRI improve structural and functional kidney evaluation without invasive procedures. Together, these innovations enable earlier treatment adjustments, reduce hospitalization risk, and support personalized kidney health management for both home-based and clinical settings.

Regenerative Kidney Therapies & Cellular Repair Technologies

Regenerative kidney therapies focus on reversing renal damage through stem cell engineering, organoid development, tissue scaffolds, and molecular reprogramming. Advanced technologies harness mesenchymal stem cells, induced pluripotent stem cells, and endothelial progenitors to restore nephron structures, reduce inflammation, and promote vascular regeneration. Bioengineered kidney organoids allow researchers to model disease progression, test drug responses, and design personalized therapies. Gene-editing platforms, including CRISPR, support correction of disease-causing mutations, opening pathways for curative treatments. Novel extracellular vesicle-based therapeutics provide cell-free regenerative signals that enhance tubular repair and reduce fibrosis. Combined with biomaterial scaffolds and 3D bioprinting, these approaches accelerate nephron reconstruction in both acute and chronic disease settings. As regenerative nephrology advances, it strengthens the possibility of delaying dialysis, reducing transplant dependence, and enabling long-term renal restoration.

Innovations in Dialysis, Wearable & Implantable Devices

Dialysis technologies are undergoing rapid evolution with the development of portable, wearable, and implantable systems that provide greater flexibility, safety, and physiological compatibility. Miniaturized hemodialysis machines, sorbent-based purification units, and automated peritoneal dialysis systems enhance patient mobility while maintaining high treatment efficiency. Wearable artificial kidney prototypes work continuously to mimic natural renal function, reducing fluid overload, metabolic imbalance, and cardiovascular strain. Implantable bio-artificial kidneys combine silicon nanotechnology and living renal cells to deliver filtration and reabsorption capacity without external power sources or immunosuppressive therapy. Intelligent dialysis systems use AI algorithms to optimize ultrafiltration rates, blood flow, and solute clearance based on real-time patient data. These innovations enhance quality of life, reduce hospitalization, and bring dialysis closer to physiological renal replacement.

Acute & Chronic Kidney Injury: Mechanisms & Early Detection

Advanced research into acute kidney injury (AKI) and chronic kidney disease (CKD) uncovers molecular pathways linked to inflammation, ischemia, oxidative stress, and fibrosis. Early-stage detection relies on sensitive biomarkers such as NGAL, KIM-1, cystatin C, and metabolomic signatures that reveal damage before creatinine rises. AI-enabled prediction models identify high-risk patients in ICUs, postoperative settings, and chronic disease populations, enabling timely interventions that prevent irreversible damage. Understanding mitochondrial dysfunction, immune dysregulation, and endothelial injury provides new therapeutic targets for nephroprotection. Emerging treatments focus on anti-fibrotic agents, cell-based repair mechanisms, and metabolic modulators that slow CKD progression. Together, these insights empower clinicians to preserve renal function and reduce long-term disease burden.

Urologic Oncology: Targeted Therapies & Biomarker Breakthroughs

Urologic oncology is accelerating through precision biomarkers, molecular diagnostics, and targeted therapies for prostate, bladder, renal, and testicular cancers. Genetic profiling helps clinicians identify tumor behavior, treatment responses, and resistance patterns. Immunotherapeutic agents, checkpoint inhibitors, antibody-drug conjugates, and precision radiotherapy improve survival outcomes with reduced toxicity. Liquid biopsies, circulating tumor DNA, and urinary biomarkers allow real-time disease monitoring and early relapse detection. Robotic-assisted surgery enables highly precise tumor removal while preserving organ function. Together, these advancements refine cancer care and support more personalized treatment pathways.

Minimally Invasive Urologic Surgery & Robotic Innovations

Minimally invasive surgery is redefining urologic care through robotic systems, advanced imaging, and miniature surgical tools. Innovations such as augmented-reality navigation and fluorescence-guided visualization enhance accuracy during tumor resections, reconstructive procedures, and stone removal. Single-port robotic surgery reduces trauma, accelerates recovery, and improves cosmetic outcomes. Energy-based modalities laser lithotripsy, plasma kinetics, and ultrasonic fragmentation enable efficient stone management with minimal complications. As technology advances, minimally invasive urology continues to enhance patient comfort and procedural precision.

Glomerular Diseases, Autoimmunity & Immune Kidney Disorders

Glomerular diseases such as lupus nephritis, IgA nephropathy, membranous nephropathy, and ANCA-associated vasculitis involve complex immune dysregulation. Advances in immunopathology help decode complement activation pathways, autoantibody profiles, and inflammatory mediators driving glomerular damage. Targeted biologics, complement inhibitors, and B-cell modulation therapies reduce disease activity with fewer systemic side effects. Molecular diagnostics and renal biopsy biomarkers improve disease classification, allowing early treatment decisions that prevent irreversible scarring. Personalized immunotherapy is emerging as a major breakthrough in improving long-term renal outcomes.

Kidney Transplantation, Xenotransplantation & Organ Preservation

Kidney transplantation is advancing with improved immunosuppressive strategies, donor-matching algorithms, and organ-preservation techniques. Hypothermic and normothermic machine perfusion enhances graft viability and reduces delayed graft function. Xenotransplantation research using gene-edited pig organs offers potential solutions to donor shortages. Tolerance-inducing therapies, such as cellular immunomodulation and regulatory T-cell expansion, reduce rejection and long-term complications. Enhanced diagnostics support early detection of rejection biomarkers, ensuring timely intervention and better graft survival.

Pediatric Nephrology & Rare Renal Genetic Disorders

Pediatric nephrology focuses on congenital anomalies, rare renal syndromes, and genetic mutations affecting kidney development and function. Early genetic screening helps identify inherited disorders such as nephronophthisis, cystinosis, and congenital nephrotic syndrome. Precision therapies—including enzyme replacement, gene therapy, and targeted biologics improve outcomes in children with rare diseases. Advanced dialysis solutions and pediatric-specific transplantation protocols provide life-saving options while minimizing developmental impacts.

Urinary Microbiome, Infection Dynamics & Host Defense

The urinary microbiome is emerging as a key regulator of urinary health, immunity, and infection susceptibility. Advanced sequencing techniques reveal microbial communities beyond traditional culture methods, reshaping understanding of recurrent UTIs, interstitial cystitis, and bladder inflammation. Novel antimicrobial peptides, vaccines, and microbiome-modulation therapies offer alternatives to conventional antibiotics. Understanding microbial-host interactions enables more accurate diagnosis and targeted treatment strategies.

Metabolic Kidney Disorders & Electrolyte Imbalance Management

Metabolic kidney disorders include nephrolithiasis, tubular abnormalities, and systemic metabolic dysfunctions. Advances in metabolic profiling help identify abnormalities in uric acid metabolism, calcium-phosphate balance, and oxalate pathways. Personalized nutritional guidance, targeted inhibitors, and metabolic therapies reduce stone recurrence and progression. Smart electrolyte monitoring technologies support early detection of life-threatening imbalances such as hyperkalemia and acidosis.

Hypertension, Cardiovascular–Renal Axis & Vascular Health

Hypertension and kidney disease share interconnected pathways involving endothelial dysfunction, RAAS imbalance, and vascular remodeling. Precision antihypertensive therapies guided by genomics and biomarkers improve control and reduce kidney damage. Renal denervation, mineralocorticoid receptor modulators, and novel vasodilatory agents offer new opportunities for patients with resistant hypertension. Integrated cardiovascular-renal management enhances patient survival and reduces complications.

Benign Urologic Conditions: Prostate, Bladder & Pelvic Health

Benign urologic disorders such as BPH, overactive bladder, pelvic floor dysfunction, and urinary incontinence impact millions worldwide. Minimally invasive therapies including laser vaporization, prostate artery embolization, and neuromodulation provide effective alternatives to surgery. Biomarker-driven diagnostics and precision therapeutics support customized treatment based on symptom severity and anatomical factors. Pelvic health innovations further enhance outcomes for both men and women.

Digital Therapeutics, Tele-Nephrology & Remote Patient Management

Digital therapeutics are reshaping renal and urologic care by enabling continuous monitoring, remote consultations, and AI-driven treatment guidance. Tele-nephrology platforms assist in managing CKD progression, medication adjustments, fluid balance, and dialysis planning. Virtual clinics increase access for rural and vulnerable populations while reducing hospitalization rates. Predictive analytics interpret patient data in real time, supporting personalized care strategies that enhance long-term kidney health.

Market Analysis

The global market for nephrology, urology, and kidney failure management is entering a transformative phase driven by rising chronic kidney disease (CKD) prevalence, demographic shifts, rapid technological innovation, and expanding access to precision diagnostics and minimally invasive therapies. CKD currently affects more than 850 million people worldwide and continues to rise due to aging populations, diabetes, hypertension, and lifestyle-related disorders. This growing disease burden is accelerating demand for advanced renal diagnostics, urologic interventions, dialysis solutions, transplantation innovations, and regenerative kidney technologies. By 2030, the global renal care market is projected to exceed USD 170 billion, with strong contributions from digital nephrology, wearable dialysis devices, urologic robotics, biopharmaceutical breakthroughs, and artificial intelligence–enabled patient management systems.

Dialysis remains a key market driver, with increasing adoption of home hemodialysis, portable devices, and fully automated monitoring tools designed to improve safety and autonomy for end-stage kidney failure patients. Innovations such as wearable artificial kidneys, sorbent-based dialysis cartridges, and electrolyte-sensing platforms are reshaping the future landscape. Simultaneously, the transplant sector is gaining momentum through organ preservation technologies, xenotransplantation research, normothermic perfusion, and regenerative medicine approaches aimed at reducing organ shortages and improving long-term graft survival. Stem-cell–based nephron repair, organoid modeling, and gene-edited donor organs represent emerging frontiers with significant commercial potential. In urology, the market is expanding rapidly due to rising prostate disorders, urinary cancers, incontinence, stone disease, and pelvic floor dysfunction. Robotic surgery, laser lithotripsy, high-precision navigation systems, and AI-enabled visualization are redefining procedural accuracy and patient outcomes. Urologic oncology continues to grow through biomarker-driven diagnostics, molecular profiling, immunotherapy combinations, and focal therapies such as HIFU and cryoablation. The integration of smart sensors, wearables, and remote monitoring for bladder health, urinary flow dynamics, and post-surgical recovery is also fueling new opportunities for digital urology. Precision medicine is a major accelerator for both nephrology and urology, with genomic risk scoring, molecular diagnostics, and machine-learning models enabling earlier detection of CKD, glomerular diseases, renal cancers, and rare hereditary conditions. Bioinformatics-driven kidney disease prediction models, AI pathology for biopsy interpretation, and cloud-based nephrology platforms are increasingly adopted in clinical practice. Meanwhile, metabolic kidney disorders, hypertension–renal axis management, and cardiorenal syndrome treatments are gaining investment focus, particularly with the success of SGLT2 inhibitors and emerging pipeline drugs targeting fibrosis, inflammation, and renal metabolic pathways. The future growth of this market is also strongly supported by tele-nephrology and digital therapeutics, providing real-time monitoring for CKD patients, remote dialysis oversight, virtual consultations, and algorithm-driven treatment optimization. These technologies are crucial in low-resource settings where access to renal specialists is limited. As global health systems prioritize early detection, equitable kidney care, and cost-effective chronic disease management, the nephrology, urology, and kidney failure sector is expected to experience sustained innovation, increased investment, and significant expansion across diagnostics, therapeutics, devices, and digital platforms.

Past Conference Report

Nephrologists 2025

The 26th Global Nephrology, Urology, and Kidney Failure Congress promises to be a pivotal event for professionals and researchers in the fields of nephrology and urology. Set against the iconic backdrop of Paris, this congress aims to foster collaboration, share the latest scientific advancements, and address the pressing challenges in kidney health and disease management. This year’s theme ‘Innovations in Dialysis Technology: From Home Dialysis to Portable Solutions’   reflects the growing importance of interdisciplinary strategies to improve patient outcomes. The congress will feature a diverse array of keynote speakers, including leading experts who will present ground breaking research and innovations in kidney therapies, dialysis techniques, and transplantation protocols. Participants can expect engaging panel discussions, workshops, and interactive sessions that delve into topics such as the psychosocial aspects of kidney disease, the role of nutrition in kidney health, and emerging biomarkers for early detection of kidney failure. Networking opportunities will abound, allowing attendees to connect with peers, share insights, and explore potential collaborations. The congress also aims to highlight global disparities in kidney care, emphasizing the need for equitable access to treatment and resources.Additionally, a poster session will provide a platform for researchers to showcase their work, fostering dialogue and collaboration among emerging scientists and established professionals. Join us in Paris to be part of this dynamic exchange of knowledge and innovation in nephrology and urology. Together, we can advance the field and improve the lives of those affected by kidney diseases worldwide. Don’t miss the chance to be at the forefront of kidney care advancements!